L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy.
D000368:Aged; D000818:Animals; D001921:Brain / Q000201:enzymology*; D001923:Brain Chemistry / Q000187:drug effects; D002262:Carboxy-Lyases / Q000378:metabolism*; D003342:Corpus Striatum / Q000201:enzymology; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005917:Globus Pallidus / Q000201:enzymology; D005971:Glutamates; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy / Q000201:enzymology*; D051381:Rats; D013378:Substantia Nigra / Q000201:enzymology
D005971:Glutamates; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases